News

PMLive3h

Boehringer’s Hernexeos granted FDA accelerated approval for lung cancer patients

Boehringer Ingelheim’s Hernexeos (zongertinib) has been granted accelerated approval by the US Food and Drug Administration ...
PMLive3h

Why life cycle management is pharma’s most underrated capability

I recently discussed this subject with Aidan Metzinger, Senior Director, Pfizer Marketing Excellence & Academy, who agrees: ...
PMLive3h

FDA approves Celltrion’s Actemra biosimilar Avtozma for cytokine release syndrome

The US Food and Drug Administration (FDA) has approved Celltrion’s intravenous (IV) formulation of Avtozma (tocilizumab-anoh) ...
PMLive4h

Why patients drop out of weight management trials and what you can do about it

Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered ...
PMLive1d

Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries

Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi ...